Breast cancer

Showing 9 of 0 results

• Behind the Research: An Exploration of Real-World Data's Ability to Support Adverse Event Surveillance at ISPOR Europe
  • Real-world evidence
  • Machine learning
  • Breast cancer
  • Regulatory
  • Post marketing requirements
• Incidence of neutropenia adverse events identified in electronic health care records among initiators of CDK4/6 inhibitors with advanced breast cancer in the UK

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Real-world study of breast cancer epidemiology and treatment patterns: A pilot study to assess EHR-derived data in the United Kingdom

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Laboratory testing patterns in patients with breast cancer treated With CDK4/6 Inhibitors: A multi-country electronic health record study from the UK, Germany, and Japan

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Comparing countries’ time to treatment initiation: A study of metastatic breast cancer in Austria and the United States

  ISPOR Europe

  • Publication summary
  • Publications
  • Metastatic breast cancer
  • Breast cancer
• Are real-world survival outcomes in metastatic breast cancer transportable between the US and Austria?

  ISPOR Europe

  • Publication summary
  • Publications
  • Metastatic breast cancer
  • Breast cancer
• Real-world insights into breast cancer in the UK: Findings from UK EHR-derived data

  ISPOR Europe

  • Publication summary
  • Publications
  • Breast cancer
• Treatment duration and subsequent treatments of first-line CDK4/6i plus aromatase inhibitor for HR+/HER2- metastatic breast cancer in US routine clinical practice

  ESMO

  • Publication summary
  • Publications
  • Comparative effectiveness
  • Breast cancer
• Real-world treatment profiles in patients with breast cancer in Japan

  DIA Japan

  • Publication summary
  • Publications
  • Breast cancer